David C Pryde (D C Pryde)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Postoperative Pain

Molecular Dynamics Simulations

Induced Pluripotent Stem Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science (New York, N.Y.)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Monali Banerjee, Sandip Middya, Ritesh Shrivastava, Sourav Basu, Rajib Ghosh, David C Pryde, Dharmendra B Yadav, Arjun Surya
G10 is a direct activator of human STING. PloS one 15 (9) (2020)
Geancarlo Zanatta, Altin Sula, Andrew J Miles, Leo C T Ng, Rubben Torella, David C Pryde, Paul G DeCaen, B A Wallace
Valproic acid interactions with the NavMs voltage-gated sodium channel. Proceedings of the National Academy of Sciences of the United States of America (2019)
Marcus Schewe, Han Sun, Ümit Mert, Alexandra Mackenzie, Ashley C W Pike, Friederike Schulz, Cristina Constantin, Kirsty S Vowinkel, Linus J Conrad, Aytuğ K Kiper, Wendy González, Marianne Musinszki, Marie Tegtmeier, David C Pryde, Hassane Belabed, Marc Nazare, Bert L de Groot, Niels Decher, Bernd Fakler, Elisabeth P Carpenter, Stephen J Tucker, Thomas Baukrowitz
A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels. Science (New York, N.Y.) 363 (6429) (2019)
Robert M Owen, David Blakemore, Lishuang Cao, Neil Flanagan, Rebecca Fish, Karl R Gibson, Rachel Gurrell, Chan Woo Huh, Juha Kammonen, Elisabeth Mortimer-Cassen, Sarah A Nickolls, Kiyoyuki Omoto, Dafydd Owen, Andy Pike, David C Pryde, David S Reynolds, Rosemarie Roeloffs, Colin Rose, Clara Stead, Mifune Takeuchi, Joseph S Warmus, Christine Watson
Design and Identification of a Novel, Functionally Subtype Selective GABAA Positive Allosteric Modulator (PF-06372865). Journal of medicinal chemistry 62 (12) (2019)
David C Pryde, N A Swain, P A Stupple, C W West, B Marron, C J Markworth, D Printzenhoff, Z Lin, P J Cox, R Suzuki, S McMurray, G J Waldron, C E Payne, J S Warmus, M L Chapman
The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics. MedChemComm 8 (6) (2017)